# Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Review · Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel, Benjamin Rossi, Romain Remark, Violette Breso, Elodie Bonnet, Guillaume Habif, Sophie Guia, Ana Inés Lalanne, Caroline Hoffmann, Olivier J Lantz, Jérôme Fayette, Agnès Boyer-Chammard, Robert Albert Zerbib, Pierre F. Dodion, Hormas Ghadially, Maria Jure‐Kunkel and 5 more

- Archive id: doi:10.1016/j.cell.2018.10.014
- Published: 2018-11-29
- Venue: Cell
- DOI: https://doi.org/10.1016/j.cell.2018.10.014
- PMID: 30503213
- Citations: 1,228
- Source URL: https://doi.org/10.1016/j.cell.2018.10.014
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.